FDA approves the first migraine prevention device

FDA approves the first transcutaneous electrical nerve stimulation (TENS) device, made by the Belgian firm STX-Med, for the prevention of migraine headaches.

The product, called Cefaly, is battery operated and resembles a plastic headband worn across the forehead.

Cefaly is available by prescription to patients aged 18 years and older. It should be used only once per day for no more than 20 minutes.

Other FDA-approved products, such as TEVA's (TEVA) Zecuity, treat migraine symptoms.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs